Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear
UCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
University of California San Francisco
Give to UCSFUCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
When a mouthful of water goes down the wrong pipe – heading toward a healthy person’s lungs instead of their gut – they start coughing uncontrollably. That’s because their upper airway senses the
Mild brain inflammation destroys arm-like projections of neurons rather than the neurons themselves, but can still cause significant brain damage.
Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2024 Grad Slam event. This year’s first-place talk was by Ilina Bhaya-Grossman on how our brains make meaning out of groups of vowels, consonants and pauses in our native tongues to recognize words.
Increased obesity worldwide has become a leading cause of cardiovascular diseases. A new study by UC San Francisco and the Broad Institute of MIT and Harvard researchers found the quantity of fat
UCSF scientists have been awarded more than $30 million to develop “tissue GPS,” a new system using engineered T cells to guide therapies directly to their targets in the brain to treat neurological diseases like cancer, multiple sclerosis and Alzheimer’s.
A smartphone app could enable greater participation in clinical trials for people with frontotemporal dementia (FTD), a devastating neurological disorder that often manifests in mid-life.
People with dementia and those who care for them should be screened for loneliness, so providers can find ways to keep them socially connected.
The Allen Institute is the newest member of the Weill Neurohub, a collaborative research network advancing treatments for neurological diseases.
Researchers recently identified a universal, essential biomarker for the childhood cancer neuroblastoma – and the biomarker could be a potential new target for treatment. Neuroblastoma accounts for
A new drug candidate permanently modifies a wily cancer-causing mutation, paving the way for making pancreatic cancer treatable, or perhaps even curable.
Delivering medicine through amniotic fluid is as effective as delivering it to the fetal brain via cerebrospinal fluid to treat serious disordrs such as Angelman syndrome.
UCSF scientists may have discovered a new way to test for autism by measuring how children’s eyes move when they turn their heads.
UCSF scientists found a way to predict Alzheimer’s disease up to seven years before symptoms appear by analyzing patient records with machine learning. Conditions that most influenced prediction of Alzheimer’s were high cholesterol and, for women, osteoporosis.
Rather than simply hearing a string of notes, the brain is assessing them for patterns and predicting which notes will be next.
Biophysicist Aashish Manglik, MD, PhD, is the newly awarded 2024 Bowes Biomedical Investigator. With the award, he hopes to further the intersection of his GPCR research and neuropsychiatric diseases.
People with depression have higher body temperatures, suggesting there could be a mental health benefit to lowering the temperatures of those with depression.
Young Black and Hispanic women with multiple sclerosis fare worse than young white women with the disease. Minority women were more likely to have more advanced disease and faced greater challenges in pregnancy.
Early identification of posterior cortical atrophy (PCA) may have important implications for Alzheimer’s treatment. PCA patients struggle with visual impairments like judging distances, distinguishing between moving and stationary objects and completing tasks like writing and retrieving a dropped item.
A newly-discovered gene may explain how humans go deaf both as they age, and in response to loud noise.
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals
Quality of sleep, not quantity, may play a part in the development of dementia decades before symptoms start.
Cell biologist and engineer Matthew Kutys, PhD, and his team harness organoids – living tissues derived from patient tumors – to study how cancer spreads.